Gene · 3708
Papers3,280
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,280
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes. | Nat Commun | 2023 | 36991000 | PubTator, text mining | PubMed |
| Neuroprotective Effects of the Neural-Induced Adipose-Derived Stem Cell Secretome against Rotenone-Induced Mitochondrial and Endoplasmic Reticulum Dysfunction. | Int J Mol Sci | 2023 | 36982698 | PubTator, text mining | PubMed |
| Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape. | Int J Mol Sci | 2023 | 36982162 | PubTator, text mining | PubMed |
| Domain Architecture of the Nonreceptor Tyrosine Kinase Ack1. | Cells | 2023 | 36980241 | PubTator, text mining | PubMed |
| Advances in Nucleotide Repeat Expansion Diseases: Transcription Gets in Phase. | Cells | 2023 | 36980167 | PubTator, text mining | PubMed |
| The Role of SNPs in the Pathogenesis of Idiopathic Central Precocious Puberty in Girls. | Children (Basel) | 2023 | 36980008 | PubTator, text mining | PubMed |
| Enhanced Ca2+-channeling complex formation at the ER-mitochondria interface underlies the pathogenesis of alcohol-associated liver disease. | Nat Commun | 2023 | 36973273 | PubTator, text mining | PubMed |
| Transcriptional drifts associated with environmental changes in endothelial cells. | Elife | 2023 | 36971339 | PubTator, text mining | PubMed |
| Control of TurboID-dependent biotinylation intensity in proximity ligation screens. | J Proteomics | 2023 | 36966971 | PubTator, text mining | PubMed |
| Role of the antineoplastic drug bleomycin based on toxicogenomic-DNA damage inducing (TGx-DDI) genomic biomarkers data: A meta-analysis. | Pak J Med Sci | 2023 | 36950431 | PubTator, text mining | PubMed |
| Single nucleus multiomics identifies ZEB1 and MAFB as candidate regulators of Alzheimer's disease-specific cis-regulatory elements. | Cell Genom | 2023 | 36950385 | PubTator, text mining | PubMed |
| Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada. | Mov Disord Clin Pract | 2023 | 36949783 | PubTator, text mining | PubMed |
| Multimodal CRISPR perturbations of GWAS loci associated with coronary artery disease in vascular endothelial cells. | PLoS Genet | 2023 | 36928188 | PubTator, text mining | PubMed |
| Neuroprotective properties of anti-apoptotic BCL-2 proteins in 5xFAD mouse model of Alzheimer's disease. | IBRO Neurosci Rep | 2023 | 36926591 | PubTator, text mining | PubMed |
| Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma. | Int J Biol Sci | 2023 | 36923933 | PubTator, text mining | PubMed |
| Immunoreactivity to astrocytes in different forms of dementia: High prevalence of autoantibodies to GFAP. | Brain Behav Immun Health | 2023 | 36923695 | PubTator, text mining | PubMed |
| Effects of calreticulin mutations on cell transformation and immunity. | J Cell Mol Med | 2023 | 36916035 | PubTator, text mining | PubMed |
Disease-specific differences in gene expression, mitochondrial function and mitochondria-endoplasmic reticulum interactions in iPSC-derived cerebral organoids and cortical neurons in schizophrenia and bipolar disorder. | Discov Ment Health | 2023 | 36915374 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages. | Int J Mol Sci | 2023 | 36902304 | PubTator, text mining | PubMed |
| Transcriptional Basis of Ca2+ Remodeling Reversal Induced by Polyamine Synthesis Inhibition in Colorectal Cancer Cells. | Cancers (Basel) | 2023 | 36900391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3708/papers?page=18